{
    "medicine_id": "1f6c85a33643b986b1b310ad2481020623fe134d",
    "platform_id": "DB04880",
    "metadata": {
        "name": "Galvus 50 mg Tablet",
        "composition": "50 mg Enoximone",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of congestive heart failure",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Enoximone is a phosphodiesterase inhibitor type III that increases the force of contraction of the heart and dilates blood vessels In June 2005 Myogen announced that they were discontinuing development of enoximone due to negative results The drug is approved for use in the UK",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00235",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Milrinone is combined with Enoximone"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Anagrelide is combined with Enoximone"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Cilostazol is combined with Enoximone"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "The risk or severity of congestive heart failure bleeding hypotension and Tachycardia can be increased when Amrinone is combined with Enoximone"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Enoximone may increase the hypotensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Enoximone can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Enoximone may increase the vasodilatory activities of Isosorbide mononitrate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}